Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil D Gross

Showing results (121-130 of 140) with videos related to

Pageof 14
Sort By:
Thyroid : Official Journal of the American Thyroid Association|February 10, 2023
Surgery After BRAF-Directed Therapy Is Associated with Improved Survival in BRAF<sup>V600E</sup> Mutant Anaplastic Thyroid Cancer: A Single-Center Retrospective Cohort StudyXiao Zhao, Jennifer Rui Wang, Ramona Dadu, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|April 30, 2026
A Standardized Algorithm's Impact on Primary Detection in Head and Neck Carcinoma of Unknown PrimaryThomas G Townes, Julian Martinez, Neil D Gross, et al.
JAMA Oncology|July 31, 2015
Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal CarcinomaEleni M Rettig, Alicia Wentz, Marshall R Posner, et al.
JCO Oncology Advances|April 2, 2026
Functional impact of transoral surgery and risk-based adjuvant therapy in human papillomavirus-associated oropharyngeal cancer: swallowing outcomes from ECOG-ACRIN E3311Katherine A Hutcheson, Yael Flamand, Beatrice Manduchi, et al.
Cancer|August 6, 2021
Elective neck dissection versus observation in patients with head and neck cutaneous squamous cell carcinomaMoran Amit, Chuan Liu, Jobran Mansour, et al.
Head & Neck|May 22, 2020
Endocrine surgery in the Coronavirus disease 2019 pandemic: Surgical Triage GuidelinesYelda Jozaghi, Mark E Zafereo, Nancy D Perrier, et al.
The Lancet. Oncology|October 24, 2023
Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 studyNeil D Gross, David M Miller, Nikhil I Khushalani, et al.
The New England Journal of Medicine|September 12, 2022
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell CarcinomaNeil D Gross, David M Miller, Nikhil I Khushalani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2022
Correction: Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and NeckRenata Ferrarotto, Moran Amit, Priyadharsini Nagarajan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2021
Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and NeckRenata Ferrarotto, Moran Amit, Priyadharsini Nagarajan, et al.
Pageof 14

Showing results (121-130 of 140) with videos related to

Sort By:
Pageof 14
Thyroid : Official Journal of the American Thyroid Association|February 10, 2023
Surgery After BRAF-Directed Therapy Is Associated with Improved Survival in BRAF<sup>V600E</sup> Mutant Anaplastic Thyroid Cancer: A Single-Center Retrospective Cohort StudyXiao Zhao, Jennifer Rui Wang, Ramona Dadu, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|April 30, 2026
A Standardized Algorithm's Impact on Primary Detection in Head and Neck Carcinoma of Unknown PrimaryThomas G Townes, Julian Martinez, Neil D Gross, et al.
JAMA Oncology|July 31, 2015
Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal CarcinomaEleni M Rettig, Alicia Wentz, Marshall R Posner, et al.
JCO Oncology Advances|April 2, 2026
Functional impact of transoral surgery and risk-based adjuvant therapy in human papillomavirus-associated oropharyngeal cancer: swallowing outcomes from ECOG-ACRIN E3311Katherine A Hutcheson, Yael Flamand, Beatrice Manduchi, et al.
Cancer|August 6, 2021
Elective neck dissection versus observation in patients with head and neck cutaneous squamous cell carcinomaMoran Amit, Chuan Liu, Jobran Mansour, et al.
Head & Neck|May 22, 2020
Endocrine surgery in the Coronavirus disease 2019 pandemic: Surgical Triage GuidelinesYelda Jozaghi, Mark E Zafereo, Nancy D Perrier, et al.
The Lancet. Oncology|October 24, 2023
Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 studyNeil D Gross, David M Miller, Nikhil I Khushalani, et al.
The New England Journal of Medicine|September 12, 2022
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell CarcinomaNeil D Gross, David M Miller, Nikhil I Khushalani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2022
Correction: Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and NeckRenata Ferrarotto, Moran Amit, Priyadharsini Nagarajan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2021
Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and NeckRenata Ferrarotto, Moran Amit, Priyadharsini Nagarajan, et al.
Pageof 14